The FDA expanded the indication of eculizumab (Soliris) to include pediatric patients ages 6 and older with generalized ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

The risk of developing MS and other demyelinating diseases is 3 times greater in individuals diagnosed with EBV-positive IM.

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

Study finds antibodies that target Epstein-Barr virus proteins can also attack proteins in the brain, increasing the ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

For the first time, researchers have found strong evidence that Epstein-Barr virus (EBV), which is best known for causing mononucleosis (or “mono”), may play a role in the development of Crohn’s ...

A new study reveals that Epstein-Barr virus (EBV) infection exacerbates ulcerative colitis (UC) by driving macrophage pyroptosis through the upregulation of glycolysis. This finding provides a ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

Natural killer cell deficiency should be considered in patients susceptible to herpes or papilloma viruses with persistently decreased NK cell function.